Gene · 6080
Papers2,015
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,015
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single- and Two-Electron Reduction of Nitroaromatic Compounds by Flavoenzymes: Mechanisms and Implications for Cytotoxicity. | Int J Mol Sci | 2021 | 34445240 | PubTator, text mining | PubMed |
| Against the Resilience of High-Grade Gliomas: Gene Therapies (Part II). | Brain Sci | 2021 | 34439595 | PubTator, text mining | PubMed |
| SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review. | Int J Biol Macromol | 2021 | 34403674 | PubTator, text mining | PubMed |
| Oncolytic Adenovirus: Prospects for Cancer Immunotherapy. | Front Microbiol | 2021 | 34367111 | PubTator, text mining | PubMed |
| Computational design of SARS-CoV-2 peptide binders with better predicted binding affinities than human ACE2 receptor. | Sci Rep | 2021 | 34341401 | PubTator, text mining | PubMed |
| A review on the advances and challenges of immunotherapy for head and neck cancer. | Cancer Cell Int | 2021 | 34332576 | PubTator, text mining | PubMed |
| Interaction of Pestiviral E1 and E2 Sequences in Dimer Formation and Intracellular Retention. | Int J Mol Sci | 2021 | 34298900 | PubTator, text mining | PubMed |
| In vitro adaptation and characterization of attenuated hypervariable region 1 swap chimeras of hepatitis C virus. | PLoS Pathog | 2021 | 34280245 | PubTator, text mining | PubMed |
| Combinatorial Approaches for Cancer Treatment Using Oncolytic Viruses: Projecting the Perspectives through Clinical Trials Outcomes. | Viruses | 2021 | 34209981 | PubTator, text mining | PubMed |
| Oncolytic Viruses in Combination Therapeutic Approaches with Epigenetic Modulators: Past, Present, and Future Perspectives. | Cancers (Basel) | 2021 | 34199429 | PubTator, text mining | PubMed |
| Prion-derived tetrapeptide stabilizes thermolabile insulin via conformational trapping. | iScience | 2021 | 34142060 | PubTator, text mining | PubMed |
| Therapy-Induced Tumor Cell Death: Friend or Foe of Immunotherapy? | Front Oncol | 2021 | 34141622 | PubTator, text mining | PubMed |
| Oncolytic Adenovirus Coding for a Variant Interleukin 2 (vIL-2) Cytokine Re-Programs the Tumor Microenvironment and Confers Enhanced Tumor Control. | Front Immunol | 2021 | 34084172 | PubTator, text mining | PubMed |
| Differential Regulation of Cellular FAM111B by Human Adenovirus C Type 5 E1 Oncogenes. | Viruses | 2021 | 34071532 | PubTator, text mining | PubMed |
| Contribution of Evolutionary Selected Immune Gene Polymorphism to Immune-Related Disorders: The Case of Lymphocyte Scavenger Receptors CD5 and CD6. | Int J Mol Sci | 2021 | 34070159 | PubTator, text mining | PubMed |
| Identification of Pyruvate Dehydrogenase E1 as a Potential Target against Magnaporthe oryzae through Experimental and Theoretical Investigation. | Int J Mol Sci | 2021 | 34068366 | PubTator, text mining | PubMed |
| Prognostic and Predictive Factors in Advanced Head and Neck Squamous Cell Carcinoma. | Int J Mol Sci | 2021 | 34067112 | PubTator, text mining | PubMed |
| Metabolic Control by DNA Tumor Virus-Encoded Proteins. | Pathogens | 2021 | 34066504 | PubTator, text mining | PubMed |
| Antiviral Activity Exerted by Natural Products against Human Viruses. | Viruses | 2021 | 34064347 | PubTator, text mining | PubMed |
| Viral Gene Therapy for Glioblastoma Multiforme: A Promising Hope for the Current Dilemma. | Front Oncol | 2021 | 34055646 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6080/papers?page=16